Sheila Connelly

6PUBLICATIONS
27CO-AUTHORS
Molecular targetsMicrobial geneticsPreventative health careMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 08, 2026
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy.

|Aug 18, 2020
Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone.

John F Kokai-Kun, Chenxiong Le, Kenneth Trout

|Feb 21, 2020
Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons.

Annalee W Nguyen, Andrea M DiVenere, James F Papin

|May 30, 2019
Oral Beta-Lactamase Protects the Canine Gut Microbiome from Oral Amoxicillin-Mediated Damage.

Sheila Connelly, Brian Fanelli, Nur A Hasan

|Jan 19, 2019
Identification, Characterization, and Formulation of a Novel Carbapenemase Intended to Prevent Antibiotic-Mediated Gut Dysbiosis.

Sheila Connelly, Todd Parsley, Hui Ge

|Mar 01, 2017
SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model.

S Connelly, J A Bristol, S Hubert

Pageof 1

Frequent Collaborators

1 joint publications

Todd Parsley

1 joint publications

Annalee W Nguyen

1 joint publications

James F Papin

1 joint publications

Michael Kaleko